ViewPoint Therapeutics Receives $4,000,000 Series A Financing

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=bd15d11f-4a2c-45ff-a911-3ca428d646a7
Date
5/6/2016
Company Name
ViewPoint Therapeutics
Mailing Address
953 Indiana St. San Francisco, CA 94107 USA
Company Description
ViewPoint Therapeutics is a biotechnology company dedicated to the development of treatments for diseases of protein misfolding, including cataracts.
Website
http://www.viewpointtherapeutics.com
Transaction Type
Venture Equity
Transaction Amount
$4,000,000
Transaction Round
Series A
Proceeds Purposes
With this financing, we plan to build on our promising preclinical results and prepare for initial human clinical studies in patients with cataracts that are poorly addressed with conventional surgery.
M&A Terms
Venture Investor
Mission Bay Capital
Venture Investor
Lagunita Capital
Venture Investor
BioVentures Investors
Venture Investor
Undisclosed
Venture Investor
Asset Management Ventures